	Ebit		Date
AbbVie	USD 5.81B	4.36B	2025-12
Amgen	USD 3.96B	464M	2025-12
Anika Therapeutics	USD -4.28M	3.58M	2025-03
Arrowhead Research	USD 40.81M	17.01M	2025-12
AstraZeneca	USD 2.97B	4.48B	2025-12
BioCryst Pharmaceuticals	USD -4.51M	12.2M	2024-12
Biogen	USD 659.6M	157M	2025-09
Bristol-Myers Squibb	USD 3.47B	567M	2025-12
Enanta Pharmaceuticals	USD -23.54M	6.31M	2024-12
Gilead Sciences	USD 2.96B	551M	2025-12
GlaxoSmithKline	GBP 1.44B	1.35B	2025-12
Halozyme Therapeutics	USD -88.41M	306.33M	2025-12
Heron Therapeutics	USD -4.46M	5.76M	2024-09
Immunic	USD -22.81M	756K	2024-06
Incyte	USD 383.88M	47.44M	2025-12
Insmed	USD -249.71M	11.64M	2025-12
Ionis Pharmaceuticals	USD -215M	54.82M	2025-12
J&J	USD 5.11B	2.3B	2025-12
Karyopharm Therapeutics	USD -26.28M	1.84M	2024-09
Ligand Pharmaceuticals	USD 158.89M	115.32M	2025-09
Merck	USD 6.24B	1.32B	2025-12
Neurocrine Biosciences	USD 227.9M	11.4M	2025-12
Novartis	USD -9.19B	13.87B	2025-06
Novavax	USD -134.02M	49.55M	2024-09
Pfizer	USD 4.65B	71M	2025-12
PTC Therapeutics	USD -81.62M	85.11M	2025-12
Roche Holding	CHF 9.56B	2.1B	2025-12
Sarepta Therapeutics	USD -410.08M	347.2M	2025-12
Vertex Pharmaceuticals	USD 1.26B	24.5M	2025-12

Enanta Pharmaceuticals - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.